arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2018 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Ocrelizumab (OCREVUS) for multiple sclerosis

    TRIMBOW and TRELEGY inhalators: triple combination for COPD (short version)

    THERAPY FROM A CRITICAL VIEWPOINT

    Nitroxoline (NITROXOLIN FORTE) against uncomplicated cystitis in women?

    a-t READER´S QUESTIONS AND COMMENTS

    Bioidentical hormones against menopausal symptoms?

    Nitro preparation PENTALONG … re-registration with the help of a delivery note

    IN BRIEF

    Increased mortality with the gout drug febuxostat (ADENURIC)

    There are still drugs without re-registration

    SIDE EFFECTS

    Diabetic ketoacidosis with SGLT2 inhibitors … pay attention and consider triggers

    CURRENT ADR NETWORK REPORT

    Enhanced effect of coumarins caused by the cough medicine noscapine (CAPVAL)
    free

    e a-t ON THE INTERNET

    TRIMBOW and TRELEGY inhalators: triple combination for COPD (long version)

    Quadrivalent influenza vaccine mandatory in the next season and reimbursed by the statutory health insurance

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles